Epigenetic modifications as targets to new therapies for Chronic Lymphocytic leukaemia - A preliminary study:
PS186
Porto Biomed J
.
2017 Sep-Oct;2(5):223.
doi: 10.1016/j.pbj.2017.07.112.
Epub 2017 Sep 1.
Authors
B Ribau
1
2
,
J Jorge
2
3
,
R Alves
2
4
,
P I Ribeiro
3
5
,
A C Gonçalves
2
4
3
,
I M Carreira
3
5
,
A B Sarmento-Ribeiro
2
4
3
6
Affiliations
1
Department of Chemistry, University of Aveiro, Portugal.
2
Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology and Applied Molecular Biology, FMUC, Portugal.
3
CIMAGO - Center of Investigation on Environment Genetics and Oncobiology, Faculty of Medicine, University of Coimbra, Portugal.
4
Center for Neuroscience and Cell Biology, IBILI (CNC.IBILI), University of Coimbra, Portugal.
5
Laboratory of Cytogenetics and Genomics (LCG), Faculty of Medicine, University of Coimbra, Portugal.
6
Clinical Hematology Service, University Hospital of Coimbra, Portugal.
PMID:
32258725
PMCID:
PMC6806895
DOI:
10.1016/j.pbj.2017.07.112
No abstract available